Atria Investments LLC Beam Therapeutics Inc. Transaction History

Atria Investments LLC

  • $8.14 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025
BUY
$14.54 - $20.24 $30,592 - $42,584
2,104 Added 21.03%
12,111 $206,000
Q1 2025

May 06, 2025
BUY
$19.53 - $34.09 $8,690 - $15,170
445 Added 4.65%
10,007 $195,000
Q4 2024

Feb 06, 2025
BUY
$21.55 - $30.35 $30,062 - $42,338
1,395 Added 17.08%
9,562 $237,000
Q3 2024

Nov 01, 2024
BUY
$22.57 - $33.14 $184,329 - $270,654
8,167 New
8,167 $200,000

Others Institutions Holding BEAM

# of Institutions
254
Shares Held
95.1M
Call Options Held
888K
Put Options Held
549K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.55B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email